199 related articles for article (PubMed ID: 29042418)
41. Alpinumisoflavone radiosensitizes esophageal squamous cell carcinoma through inducing apoptosis and cell cycle arrest.
Zhang B; Fan X; Wang Z; Zhu W; Li J
Biomed Pharmacother; 2017 Nov; 95():199-206. PubMed ID: 28843908
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
43. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
[TBL] [Abstract][Full Text] [Related]
44. Radiation-induced autophagy promotes esophageal squamous cell carcinoma cell survival via the LKB1 pathway.
Lu C; Xie C
Oncol Rep; 2016 Jun; 35(6):3559-65. PubMed ID: 27109915
[TBL] [Abstract][Full Text] [Related]
45. Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
Qian X; Tan C; Yang B; Wang F; Ge Y; Guan Z; Cai J
Dis Esophagus; 2017 Jun; 30(6):1-7. PubMed ID: 28475750
[TBL] [Abstract][Full Text] [Related]
46. STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α.
Zhang C; Yang X; Zhang Q; Guo Q; He J; Qin Q; Zhu H; Liu J; Zhan L; Lu J; Liu Z; Xu L; Ma J; Dai S; Cheng H; Sun X
Tumour Biol; 2014 Oct; 35(10):9793-9. PubMed ID: 24981247
[TBL] [Abstract][Full Text] [Related]
47. Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.
Chen JL; Chen JP; Huang YS; Tsai YC; Tsai MH; Jaw FS; Cheng JC; Kuo SH; Shieh MJ
Strahlenther Onkol; 2016 Apr; 192(4):260-8. PubMed ID: 26952039
[TBL] [Abstract][Full Text] [Related]
48. Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma.
Luo H; Song H; Mao R; Gao Q; Feng Z; Wang N; Song S; Jiao R; Ni P; Ge H
Cancer Sci; 2019 Nov; 110(11):3464-3475. PubMed ID: 31454136
[TBL] [Abstract][Full Text] [Related]
49. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma.
Li MY; Fan LN; Han DH; Yu Z; Ma J; Liu YX; Li PF; Zhao DH; Chai J; Jiang L; Li SL; Xiao JJ; Duan QH; Ye J; Shi M; Nie YZ; Wu KC; Liao DJ; Shi Y; Wang Y; Yan QG; Guo SP; Bian XW; Zhu F; Zhang J; Wang Z
J Clin Invest; 2020 Aug; 130(8):4301-4319. PubMed ID: 32396532
[TBL] [Abstract][Full Text] [Related]
50. High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy.
Ma H; Zheng S; Zhang X; Gong T; Lv X; Fu S; Zhang S; Yin X; Hao J; Shan C; Huang S
Cell Death Dis; 2019 Feb; 10(2):136. PubMed ID: 30755598
[TBL] [Abstract][Full Text] [Related]
51. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
52. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins.
Wang D; Qin Q; Jiang QJ; Wang DF
J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
Zhao Y; Ma K; Yang S; Zhang X; Wang F; Zhang X; Liu H; Fan Q
Int J Oncol; 2018 Aug; 53(2):644-658. PubMed ID: 29767234
[TBL] [Abstract][Full Text] [Related]
54. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
Nakatani K; Serada S; Fujimoto M; Obata K; Ohkawara T; Sasabe E; Yamamoto T; Naka T
J Oral Pathol Med; 2022 Feb; 51(2):126-133. PubMed ID: 34878693
[TBL] [Abstract][Full Text] [Related]
55. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
56. Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivo.
Zhao H; Gu X
World J Surg Oncol; 2014 Nov; 12():325. PubMed ID: 25363593
[TBL] [Abstract][Full Text] [Related]
57. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
58. [Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma].
Huo YQ; Ruan X; DU XL; Shang L; Cai Y; Xu X; Wang MR; Zhang Y; Fu SB
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):579-84. PubMed ID: 24314214
[TBL] [Abstract][Full Text] [Related]
59. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
60. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
Harada T; Harada K; Ueyama Y
Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]